Lowest Price Guaranteed From USD 5,899
Published
January 2021
Pages
184
View Count
5796
Example Insights
-thumb.PNG) |
 |
 |
-thumb.PNG) |
 |
-thumb.PNG) |
 |
 |
Report Description
Small molecule drugs account for nearly 90% of the contemporary therapeutics pipeline. In fact, in 2019, the FDA’s Center for Drug Evaluation and Research approved 48 small molecule drugs, representing 70% of the new molecular entities (NMEs) clearing regulatory review in the same year. Given that the demand for small molecule drugs is still on the rise, the importance of contract manufacturing and third party services is also increasing in the pharmaceutical industry. Sterile fill / finish is considered among the most crucial steps in the pharmaceutical production process. In fact, aseptic conditions during fill / finish operations are not only essential for ensuring end user safety, but also maintaining pharmacological efficacy and product quality. As small molecule APIs are gradually becoming more complex, the demand for appropriate aseptic fill / finish processes is growing.
Given the high cost of specialized equipment and the affiliated expertise required for aseptic fill / finish operations, it is difficult for drug developer companies with limited finances and capacity constraints to meet clinical / commercial scale demands. This has led many of the smaller players in the industry and certain pharma giants, as well, to outsource various aspects of their production processes, including fill / finish, to contract service providers. Currently, over 130 companies are actively providing sterile fill / finish services for small molecules. In the recent past, many of the aforementioned service providers have also forged strategic alliances and / or acquired other players, in order to further enhance their respective service offerings. We believe that this trend is likely to persist in the foreseen future, as well. Overall, the contract services market for fill / finish of small molecule drugs is anticipated to witness steady growth, till 2030.
The ‘Sterile Small Molecule Fill / Finish Services Market, 2020-2030’ report features an extensive study of the current market landscape and the future potential of sterile fill / finish services for small molecule drugs. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
One of the key objectives of the report was to estimate the existing market size and potential growth opportunities for sterile small molecule service providers. Based on parameters, such as such as growth of the overall pharmaceutical market, the cost associated with fill / finish operation and outsourcing trends related to these operations, we have provided an informed estimate on the likely evolution of the market over the period 2020-2030. Our year-wise projections of the current and future opportunity have further been segmented on the basis of
[A] fill / finish technique (aseptic filling, terminal sterilization and blow-fill-seal)
[B] type of packaging (ampoules, bottles, pre-filled syringes and vials)
[C] type of dosage form (liquid, lyophilized and others)
[D] key geographical regions (North America (US, Canada), Europe (UK, France, Germany, Italy, Spain and rest of the Europe), Asia-Pacific (Australia, India, South Korea and rest of the Asia), Middle East and North Africa and Latin America).
To account for the uncertainties associated with this industry and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Contents
Chapter 2 is an executive summary of the insights captured in our research. The summary offers a high-level view on the likely evolution of the sterile small molecule service providers market in the mid to long term.
Chapter 3 provides a general introduction to pharmaceutical contract manufacturing industry. The chapter lays emphasis on the important sterile fill / finish techniques that are being adopted by the industry for packaging of small molecule drugs. It includes information on key factors that need to be considered during the selection of fill / finish service providers, as well as the advantages and associated risks or challenges related to outsourcing fill / finish operations.
Chapter 4 provides an overview of the overall sterile small molecule fill / finish contract services landscape. It includes information related to 130 contract service providers that are currently active in this domain. It features in-depth analyses of the market, based on a number of relevant parameters, such as year of establishment, company size and geographical location of the service providers, location of fill / finish facilities, information on various fill / finish techniques (aseptic filling, terminal sterilization and blow-fill-seal), types of dosage form (liquid, lyophilized, micelles / liposomes and powder / others), types of packaging (ampoules / vials, cartridges / pre-filled syringes / syringes and bottles / others) and scale of operation (preclinical, clinical and commercial).
Chapter 5 provides an insightful competitiveness analysis of the service providers that we came across during our research. The analysis compares the companies on the basis of supplier strength (based on the year of establishment of the service provider) and service portfolio strength (which takes into account the number of dosage forms handled, number of containers for which fill / finish service is being provided, number of fill / finish techniques adopted and scale of operation).
Chapter 6 features detailed profiles of some of the key players that are active in the sterile small molecule contract manufacturing domain. Each profile presents a brief overview of the company, its fill / finish service portfolio, financial information (if available), recent developments and an informed future outlook.
Chapter 7 presents detailed analyses of the expansions that have taken place since 2016. These have been analyzed on various parameters, including year of expansion, purpose of expansion (capacity expansion, capability expansion, new facility, geographical consolidation and geographical expansion), geographical location of the facility, and also highlights the most active players (in terms of number of instances) in the domain.
Chapter 8 features a comprehensive analysis of the global sterile small molecule fill / finish capacity, by taking into consideration the container processing capacities of various fill / finish service providers (as available on respective company websites). The study examines the distribution of global sterile small molecule fill / finish capacity of the industry in terms of number of packaging units, type of packaging (ampoules, bottles, pre-filled syringes and vials), size of the manufacturer (small-sized, mid-sized and large / very large) and geography (North America, Europe and Asia-Pacific).
Chapter 9 presents a comprehensive market forecast analysis, highlighting the likely growth of sterile small molecules’ fill / finish services market till the year 2030. In order to provide a detailed future outlook, our projections have been segmented on the basis of fill / finish technique (aseptic filling, terminal sterilization and blow-fill-seal), type of packaging (ampoules, bottles, pre-filled syringes and vials), type of dosage form (liquid, lyophilized and other dosage form), and key geographical regions (North America (US, Canada), Europe (UK, France, Germany, Italy, Spain and rest of the Europe), Asia (Australia, India, South Korea and rest of the Asia), Middle East and North Africa and Latin America).
Chapter 10 is a case study focused on use of robotic systems in fill / finish operations. It provides a list of equipment used for fill / finish, highlighting the role of robotics in various manufacturing operations. It also includes list of companies providing robots for use in pharmaceutical production processes.
Chapter 11 is a case study which describes the use of ready-to-use packaging components in the aseptic fill / finish operations. It also provides a list of suppliers providing ready-to-use components.
Chapter 12 summarizes the entire report. It presents a list of key takeaways and offers our independent opinion on the current market scenario.
Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.
Chapter 14 is an appendix, which provides the list of companies and organizations mentioned in the report.
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Question Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Fill / Finish of Small Molecule Drugs
3.2.1. Aseptic Filling
3.2.2. Terminal Sterilization
3.2.3. Blow-Fill-Seal Technology
3.3. Guidelines for Selecting a Fill / Finish Service Provider
3.4. Risks and Challenges of Outsourcing Fill / Finish Operations
3.5. Advantages of Outsourcing Fill / Finish Operations
4. MARKET LANDSCAPE: STERILE SMALL MOLECULE FILL / FINISH SERVICE PROVIDERS
4.1. Chapter Overview
4.2. Sterile Small Molecule Fill / Finish Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size and Location of Headquarters
4.2.3. Analysis by Location of Fill / Finish Facilities
4.2.4. Analysis by Type of Fill / Finish Technique
4.2.5. Analysis by Type of Packaging
4.2.6. Analysis by Type of Dosage Forms Filled
4.2.7. Analysis by Scale of Operation
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3 Assumptions and Key Parameters
5.3.1. Competitiveness Analysis: Aseptic Small Molecule Fill / Finish Service Providers in North America
5.3.2. Competitiveness Analysis: Aseptic Small Molecule Fill / Finish Service Providers in Europe
5.3.3. Competitiveness Analysis: Aseptic Small Molecule Fill / Finish Service Providers in Asia-Pacific
5.4. Contact Details of Key Service Providers
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Albany Molecular Research (AMRI)
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Pii (Pharmaceutics International)
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Ajinomoto Bio-Pharma Services
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. Catalent Pharma Solutions
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Service Portfolio
6.5.4. Recent Developments and Future Outlook
6.6. Pfizer CentreOne
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Service Portfolio
6.6.4. Recent Developments and Future Outlook
6.7. Delpharm
6.7.1. Company Overview
6.7.2. Service Portfolio
6.7.3. Recent Developments and Future Outlook
6.8. Rompharm
6.8.1. Company Overview
6.8.2. Service Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. CordenPharma
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. Service Portfolio
6.9.4. Recent Developments and Future Outlook
6.10. Mithra CDMO
6.10.1. Company Overview
6.10.2. Financial Information
6.10.3. Service Portfolio
6.10.4. Recent Developments and Future Outlook
6.11. Pierre Fabre
6.11.1. Company Overview
6.11.2. Financial Information
6.11.3. Service Portfolio
6.11.4. Recent Developments and Future Outlook
6.12. APL
6.12.1. Company Overview
6.12.2. Service Portfolio
6.12.3. Recent Developments and Future Outlook
6.13. Square Pharmaceuticals
6.13.1. Company Overview
6.13.2. Financial Information
6.13.3. Service Portfolio
6.13.4. Recent Developments and Future Outlook
6.14. Wockhardt
6.14.1. Company Overview
6.14.2. Financial Information
6.14.3. Service Portfolio
6.14.4. Recent Developments and Future Outlook
7. RECENT EXPANSIONS
7.1. Chapter Overview
7.2. Sterile Small Molecule Fill / Finish Service Providers Market: Expansion Models
7.2.1. Analysis by Year of Expansion
7.2.2. Analysis by Purpose of Expansion
7.2.3. Analysis by Year of Expansion and Purpose of Expansion
7.2.4. Analysis by Company Size and Location of Headquarters
7.2.5. Analysis by Purpose of Expansion and Location of Facility
7.2.6. Most Active Players: Analysis by Number of Expansions
7.2.7. Analysis by Geographical Distribution
8. CAPACITY ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Methodology
8.3. Global Installed Small Molecule Fill / Finish Capacity (by Number of Units)
8.3.1. Analysis by Type of Packaging
8.3.2. Analysis by Size of Manufacturer
8.3.3. Analysis by Location of Headquarters
8.4. Global Installed Small Molecule Fill / Finish Capacity (by Volume)
8.4.1. Analysis by Type of Packaging
8.4.2. Analysis by Size of Manufacturer
8.4.3. Analysis by Location of Headquarters
9. MARKET SIZING AND OPPORTUNITY ANALYSIS
9.1. Chapter Overview
9.2. Forecast Methodology
9.3. Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030
9.3.1. Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Fill / Finish Technique
9.3.2. Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Type of Packaging
9.3.3. Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Type of Dosage Form
9.3.4. Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Geographical Region
9.3.4.1 Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Countries
9.3.4.2. Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Fill / Finish Technique
9.3.4.3. Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Type of Packaging
9.3.4.4. Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Type of Dosage Form
9.3.4.5. Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Countries
9.3.4.6. Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Fill / Finish Technique
9.3.4.7. Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Type of Packaging
9.3.4.8. Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Type of Dosage Form
9.3.4.9. Sterile Small Molecule Fill / Finish Services Market in Asia Pacific, 2020-2030: Distribution by Countries
9.3.4.10. Sterile Small Molecule Fill / Finish Services Market in Asia Pacific, 2020-2030: Distribution by Fill / Finish Technique
9.3.4.11. Sterile Small Molecule Fill / Finish Services Market in Asia Pacific, 2020-2030: Distribution by Type of Packaging
9.3.4.12. Sterile Small Molecule Fill / Finish Services Market in Asia Pacific, 2020-2030: Distribution by Type of Dosage Form
9.3.4.13. Sterile Small Molecule Fill / Finish Services Market in Middle East and North Africa, 2020-2030: Distribution by Countries
9.3.4.14. Sterile Small Molecule Fill / Finish Services Market in Middle East and North Africa, 2020-2030: Distribution by Fill / Finish Technique
9.3.4.15. Sterile Small Molecule Fill / Finish Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Packaging
9.3.4.16. Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Countries
9.3.4.17. Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Fill / Finish Technique
9.3.4.18. Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Type of Packaging
9.3.4.19. Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Type of Dosage Form
10. CASE STUDY: ROBOTIC SYSTEMS IN FILL / FINISH OPERATIONS
10.1. Chapter Overview
10.2. Contract Service Providers: List of Fill / Finish Equipment
10.3. Role of Robotic Systems in Fill / Finish Operations
10.3.1. Types of Robots Used in Pharmaceutical Operations
10.3.2. Key Considerations for Selecting a Robotic System
10.3.3. Advantages of Robotic Systems
10.3.4. Disadvantages of Robotic Systems
10.4. Companies Providing Robots for Use in the Pharmaceutical Industry
10.5. Concluding Remarks
11. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS IN ASEPTIC FILL / FINISH OPERATIONS
11.1. Chapter Overview
11.2. Role of Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations
11.2.1. Advantages of Ready-to-Use Packaging Components
11.2.2. Disadvantages of Ready-to-Use Packaging Components
11.3. Companies Providing Ready-to-Use Packaging Components
11.4. Concluding Remarks
12. CONCLUDING REMARKS
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 3.1 Fill / Finish Process Map
Figure 3.2 Blow Fill Seal Process
Figure 3.3 Key Considerations for Selecting a CMO Partner
Figure 3.4 Risks and Challenges of Outsourcing Fill / Finish Operations
Figure 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 4.2 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Company Size and Location of Headquarters
Figure 4.3 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Figure 4.4 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Type of Fill / Finish Technique
Figure 4.5 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Type of Packaging
Figure 4.6 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Type of Dosage Forms Filled
Figure 4.7 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Scale of Operation
Figure 5.1 Competitiveness Analysis: Sterile Small Molecule Fill / Finish Service Providers in North America
Figure 5.2 Competitiveness Analysis: Sterile Small Molecule Fill / Finish Service Providers in Europe
Figure 5.3 Competitiveness Analysis: Sterile Small Molecule Fill / Finish Service Providers in Asia-Pacific
Figure 6.1 Catalent Pharma Solutions: Annual Revenues, 2016-2019 (USD Million)
Figure 6.2 Pfizer CentreOne: Annual Revenues, 2016-2019 (USD Million)
Figure 6.3 CordenPharma: Annual Revenues, 2018-2019 (EUR Million)
Figure 6.4 Mithra CDMO: Annual Revenues, 2016-2019 (EUR Million)
Figure 6.5 Pierre Fabre: Annual Revenues, 2016-2019 (EUR Billion)
Figure 6.6 Square Pharmaceuticals: Annual Revenues, 2016-2019 (BDT Billion)
Figure 6.7 Wockhardt: Annual Revenues, 2016-2019 (USD Million)
Figure 7.1 Recent Expansions: Cumulative Year-Wise Trend, 2016-2020 (Till June)
Figure 7.2 Recent Expansions: Distribution by Purpose of Expansion
Figure 7.3 Recent Expansion: Distribution by Purpose of Expansion and Year of Expansion (2016-2020)
Figure 7.4 Recent Expansions: Distribution by Location of Headquarters and Company Size
Figure 7.5 Recent Expansions: Distribution by Location of Facility and Purpose of Expansion
Figure 7.6 Most Active Players: Distribution by Number of Recent Expansions
Figure 7.7 Recent Expansions: Distribution by Geography and Year, 2016-2020
Figure 8.1 Global Installed Small Molecule Fill / Finish Capacity (by Number of Units)
Figure 8.2 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Type of Packaging (by Number of Units)
Figure 8.3 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Size of Manufacturer (by Number of Units)
Figure 8.4 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Location of Headquarters (by Number of Units)
Figure 8.5 Global Installed Small Molecule Fill / Finish Capacity (by Volume)
Figure 8.6 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Type of Packaging (by Volume)
Figure 8.7 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Size of Manufacturer (by Volume)
Figure 8.8 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Location of Headquarters (by Volume)
Figure 9.1 Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030 (USD Million)
Figure 9.2 Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Figure 9.3 Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Type of Packaging (USD Million)
Figure 9.4 Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Figure 9.5 Global, Sterile Small Molecule Fill / Finish Services Market, 2020-2030: Distribution by Geographical Region (USD Million)
Figure 9.6 Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Countries (USD Million)
Figure 9.7 Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Figure 9.8 Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Type of Packaging (USD Million)
Figure 9.9 Sterile Small Molecule Fill / Finish Services Market in North America, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Figure 9.10 Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Countries (USD Million)
Figure 9.11 Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Figure 9.12 Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Type of Packaging (USD Million)
Figure 9.13 Sterile Small Molecule Fill / Finish Services Market in Europe, 2020-2030: Distribution by Type of Dosage Form, 2020-2030 (USD Million)
Figure 9.14 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, 2020-2030: Distribution by Countries (USD Million)
Figure 9.15 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Figure 9.16 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, 2020-2030: Distribution by Type of Packaging (USD Million)
Figure 9.17 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Figure 9.18 Sterile Small Molecule Fill / Finish Services Market in Middle East and North Africa, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Figure 9.19 Sterile Small Molecule Fill / Finish Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Packaging (USD Million)
Figure 9.20 Sterile Small Molecule Fill / Finish Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Figure 9.21 Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Figure 9.22 Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Type of Packaging (USD Million)
Figure 9.23 Sterile Small Molecule Fill / Finish Services Market in Latin America, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Figure 10.1 Key Considerations for Selecting a Robotic System
Figure 10.2 Advantages of Robotic Systems in Pharmaceutical Operations
Figure 11.1 Drivers of Ready-to-Use Platform
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: List of Companies
Table 4.1 Key Service Providers’ Contact Details
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: List of Companies Profiled
Table 4.1 Albany Molecular Research (AMRI): Recent Developments and Future Outlook
Table 4.1 Pii (Pharmaceutics International): Recent Developments and Future Outlook
Table 4.1 Ajinomoto Bio-Pharma Services: Recent Developments and Future Outlook
Table 4.1 Catalent Pharma Solutions: Recent Developments and Future Outlook
Table 4.1 Pfizer CentreOne: Recent Developments and Future Outlook
Table 4.1 Delpharm: Recent Developments and Future Outlook
Table 4.1 Rompharm: Recent Developments and Future Outlook
Table 4.1 CordenPharma: Recent Developments and Future Outlook
Table 4.1 Mithra CDMO: Recent Developments and Future Outlook
Table 4.1 Pierre Fabre: Recent Developments and Future Outlook
Table 4.1 APL: Recent Developments and Future Outlook
Table 4.1 Square Pharmaceuticals: Recent Developments and Future Outlook
Table 4.1 Wockhardt: Recent Developments and Future Outlook
Table 4.1 Sterile Small Molecule Fill / Finish Services: List of Recent Expansions
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Information on Equipment Used
Table 4.1 List of Pharmaceutical Robotics Manufacturers
Table 4.1 List of Companies Supplying Ready-to-Use Packaging Components
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Year of Establishment
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Company Size and Location of Headquarters
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Type of Fill / Finish Technique
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Type of Packaging
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Type of Dosage Forms Filled
Table 4.1 Sterile Small Molecule Fill / Finish Service Providers: Distribution by Scale of Operation
Table 4.1 Catalent Pharma Solutions: Annual Revenues, 2016-2019 (USD Million)
Table 4.1 Pfizer CentreOne: Annual Revenues, 2016-2019 (USD Million)
Table 4.1 CordenPharma: Annual Revenues, 2018-2019 (EUR Million)
Table 4.1 Mithra CDMO: Annual Revenues, 2016-2019 (EUR Million)
Table 4.1 Pierre Fabre: Annual Revenues, 2016-2019 (EUR Billion)
Table 4.1 Square Pharmaceuticals: Annual Revenues, 2016-2019 (BDT Billion)
Table 4.1 Wockhardt: Annual Revenues, 2016-2019 (USD Million)
Table 4.1 Recent Expansions: Cumulative Year-Wise Trend, 2016-2020 (Till June)
Table 4.1 Recent Expansions: Distribution by Purpose of Expansion
Table 4.1 Recent Expansion: Distribution by Purpose of Expansion and Year of Expansion (2016-2020)
Table 4.1 Recent Expansions: Distribution by Location of Headquarters and Company Size
Table 4.1 Recent Expansions: Distribution by Location of Facility and Purpose of Expansion
Table 4.1 Most Active Players: Distribution by Number of Recent Expansions
Table 4.1 Recent Expansions: Distribution by Geography and Year, 2016-2020
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity (by Number of Units)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Type of Packaging (by Number of Units)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Size of Manufacturer (by Number of Units)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Location of Headquarters (by Number of Units)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity (by Volume)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Type of Packaging (by Volume)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Size of Manufacturer (by Volume)
Table 4.1 Global Installed Small Molecule Fill / Finish Capacity: Distribution by Location of Headquarters (by Volume)
Table 4.1 Global, Sterile Small Molecule Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2020-2030 (USD Million)
Table 4.1 Global, Sterile Small Molecule Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Table 4.1 Global, Sterile Small Molecule Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Packaging (USD Million)
Table 4.1 Global, Sterile Small Molecule Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Table 4.1 Global, Sterile Small Molecule Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Geographical Region (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Countries (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Packaging (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Countries (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Packaging (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Dosage Form (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Countries (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Fill / Finish Technique (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Packaging (USD Million)
Table 4.1 Sterile Small Molecule Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2020-2030: Distribution by Type of Dosage Form (USD Million)
PRICING DETAILS
Discounts available for multiple report purchases
sales@rootsanalysis.com
YOU MAY ALSO LIKE
SUBSCRIBE TO INDUSTRY UPDATES